With a revenue increase of 26.97% in the second quarter 2026, year on year to cumulative value of $1,668 million, Alkermes Plc 's revenue per employee grew on a trailing twelve months basis to $ 813,489. The productivity of Alkermes Plc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 111 other companies have achieved higher revenue per employee. While Alkermes Plc 's total ranking has deteriorated compared to the previous quarter from 459 to 1105. Alkermes Plc has 2,050 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALKS Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	26.97 %	28.19 %	-10.57 %	4.24 %	-2.12 %
Sales per Employee (TTM) $	813,489	762,098	719,951	742,116	734,291
ALKS's Total Ranking	# 1105	# 459	# 857	# 192	# 315
Seq. Revenue Change	26.24 %	2.18 %	-2.45 %	0.9 %	27.45 %

ALKS Company Profile >> Back to ALKS Efficiency Comparisons >> Compare ALKS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 77
Healthcare Sector	# 112
Overall Market	# 1105

Revenue per Employee Statistics
High	Average	Low
$ 842,040	$ 528,711	$ 281,836
(Mar 31 2024)		(Sep 30 2013)

Financial Statements
Alkermes Plc 's Revenue MRQ	$ 496 Millions	Visit ALKS's Income Statement
Alkermes Plc 's Revenues TTM	$ 1,668 Millions	Visit ALKS's aggregate revenue growth
What are ALKS's Sales?		Visit ALKS's Sales by Segment

Other Ratios
Alkermes Plc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ALKS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ALKS's Competitors
Revenue per Employee for ALKS's Suppliers
Revenue per Employee for ALKS's Customers

You may also want to know
ALKS's Sales Growth Rates	ALKS's Pe Price to earnings ratio	ALKS's Receivables Turnover Ratio	ALKS's Stock Quote
ALKS's Net Income Growth Rates	ALKS's Ps Price to Sales ratio	ALKS's Sales per Employee	ALKS's Asset Turnover Ratio
ALKS's Net Margin	ALKS's Pb Price to Book ratio	ALKS's Financial Strength Ratios	ALKS's Dividend Payout Ratio

Date modified: 2026-07-29T06:45:55+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Cue Biopharma Inc	1,298,413.79	$ 37.654 Million	29
Arvinas Inc	1,287,398.37	$ 316.700 Million	246
Travere Therapeutics Inc	1,189,798.79	$ 591.330 Million	497
Heron Therapeutics Inc	1,183,648.44	$ 151.507 Million	128
Journey Medical Corp	1,175,534.48	$ 68.181 Million	58
Theravance Biopharma inc	1,159,011.11	$ 104.311 Million	90
Corcept Therapeutics Inc	1,138,100.00	$ 830.813 Million	730
Biomarin Pharmaceutical Inc	1,057,626.20	$ 3,406.614 Million	3,221
Hims and Hers Health Inc	1,055,894.35	$ 2,578.494 Million	2,442
Assembly Biosciences Inc	1,025,273.97	$ 74.845 Million	73
Sanara Medtech Inc	1,019,592.91	$ 110.116 Million	108
Ani Pharmaceuticals Inc	1,008,638.14	$ 978.379 Million	970
Coya Therapeutics Inc	1,002,393.13	$ 8.019 Million	8
Meiragtx Holdings Plc	986,354.84	$ 397.501 Million	403
Arrowhead Pharmaceuticals Inc	941,624.47	$ 669.495 Million	711
Scilex Holding Company	929,647.06	$ 31.608 Million	34
The Oncology Institute Inc	916,137.29	$ 587.244 Million	641
Pacira Biosciences inc	900,077.20	$ 746.164 Million	829
Fortress Biotech Inc	897,217.95	$ 69.983 Million	78
Alphatec Holdings Inc	892,420.59	$ 814.780 Million	913
Merck and Co Inc	887,586.67	$ 66,569.000 Million	75,000
Nektar Therapeutics	866,492.06	$ 54.589 Million	63
Bridgebio Pharma Inc	849,903.46	$ 713.069 Million	839
Pfizer Inc	849,280.00	$ 63,696.000 Million	75,000
Syndax Pharmaceuticals Inc	845,651.01	$ 252.004 Million	298
Xilio Therapeutics Inc	843,315.79	$ 64.092 Million	76
Axsome Therapeutics Inc	839,534.05	$ 776.569 Million	925
Ionis Pharmaceuticals Inc	834,107.70	$ 1,169.419 Million	1,402
Immunocore Holdings Plc	822,089.69	$ 430.775 Million	524
Alkermes Plc	813,488.78	$ 1,667.652 Million	2,050

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.